FDA Wants Compounding Authority Clarified, Congress Not So Sure It’s Necessary
This article was originally published in The Pink Sheet Daily
Executive Summary
Commissioner Hamburg asks for more power over non-traditional compounding to better regulate companies like the New England Compounding Center, but several House members say it looks like the agency already has the authority it needs.
You may also be interested in...
FDA Drugs Field Staff May Be Based In Four Offices After Realignment
Pharmaceutical-focused field offices are another result of FDA’s Program Alignment Group process.
FDA Drugs Field Staff May Be Based In Four Offices After Realignment
Pharmaceutical-focused field offices are another result of FDA’s Program Alignment Group process.
FDA Drugs Field Staff May Be Based In Four Offices After Realignment
Pharmaceutical-focused field offices are another result of FDA’s Program Alignment Group process.